About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

AGM Chairman’s Address and CEO Presentation

May 28, 2018

Click here to read more

Post navigation

CEO Roadshow Presentation

2018 AGM Results

Related Posts

Phosphagenics Entitlement Offer Raises Over AUD3M

October 25, 2017

Phosphagenics’ PHN Trial Completes Enrolment and Dosing

December 17, 2015

Reformulation of Phosphagenics Transdermal TPM/Oxymorphone Patch Complete

December 12, 2016

Recent Posts

$5.06m Placement Complete
February 9, 2021
Interview with Peter Switzer
January 19, 2021
Observational study testing enhanced CBD formulation
December 22, 2020

Categories

Analyst Coverage
Company Announcement
Company Report
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.